Literature DB >> 16552844

The study of electroacupuncture on cerebral blood flow in rats with and without cerebral ischemia.

Ching-Liang Hsieh1, Qwang-Yuen Chang, I-hsin Lin, Jaung-Geng Lin, Chung-Hsiang Liu, Nou-Ying Tang, Hsien-Yuan Lane.   

Abstract

Electroacupuncture (EA) is widely used to treat disorders of the nervous system, such as stroke. The aim of the present study was to investigate the effect of EA on cerebral blood flow (CBF) in cerebral ischemic rats. We developed an animal model of cerebral ischemia (CI) by occluding the blood flow of both common carotid arteries in Sprague-Dawley (SD) rats; 2 or 15 Hz EA was applied to both Zusanli acupoints. The levels of nitric oxide (NO) in the peripheral blood and amounts of calcitonin gene-related peptide (CGRP) in the cerebral cortex and thalamus were measured. In addition, L-N (G)-nitro arginine methyl ester (L-NAME) was used to measure the changes in CBF induced by EA in rats with and without CI. The results indicated that both 2 and 15 Hz EA increase the mean CBF in rats with and without CI. However, neither 2 nor 15 Hz EA induced changes in levels of NO in peripheral blood or changes in CGRP levels in cerebral cortex and thalamus. In addition, L-NAME did not change the increase in CBF. We concluded that both 2 and 15 Hz EA at both Zusanli acupoints induced the increase of CBF in rats with and without CI. Whether the effect of EA is related to NO or CGRP will be investigated in a future study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552844     DOI: 10.1142/S0192415X06003886

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  9 in total

Review 1.  The neuroprotective effect of electro-acupuncture against ischemic stroke in animal model: a review.

Authors:  Rui Feng; Feng Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

2.  Zusanli (ST36) Acupoint Injection for Diabetic Peripheral Neuropathy: A Systematic Review of Randomized Controlled Trials.

Authors:  Li-Qiong Wang; Zhuo Chen; Kang Zhang; Ning Liang; Guo-Yan Yang; Lily Lai; Jian-Ping Liu
Journal:  J Altern Complement Med       Date:  2018-09-26       Impact factor: 2.579

Review 3.  Mechanisms of Acupuncture Therapy for Cerebral Ischemia: an Evidence-Based Review of Clinical and Animal Studies on Cerebral Ischemia.

Authors:  Wen Zhu; Yang Ye; Yi Liu; Xue-Rui Wang; Guang-Xia Shi; Shuai Zhang; Cun-Zhi Liu
Journal:  J Neuroimmune Pharmacol       Date:  2017-05-19       Impact factor: 4.147

4.  Neuronal Regeneration after Electroacupuncture Treatment in Ischemia-Reperfusion-Injured Cerebral Infarction Rats.

Authors:  Shiang-Lin Liao; Yi-Wen Lin; Ching-Liang Hsieh
Journal:  Biomed Res Int       Date:  2017-08-24       Impact factor: 3.411

Review 5.  Effect of Acupuncture on the p38 Signaling Pathway in Several Nervous System Diseases: A Systematic Review.

Authors:  Tzu-Hsuan Wei; Ching-Liang Hsieh
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

6.  Electroacupuncture Preconditioning Reduces Oxidative Stress in the Acute Phase of Cerebral Ischemia-Reperfusion in Rats by Regulating Iron Metabolism Pathways.

Authors:  Runyu Liang; Qiang Tang; Wenjing Song; Mei Zhang; Lili Teng; Yuying Kang; Luwen Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-08       Impact factor: 2.629

7.  Electroacupuncture improves recovery after hemorrhagic brain injury by inducing the expression of angiopoietin-1 and -2 in rats.

Authors:  Hua-Jun Zhou; Tao Tang; Jian-Hua Zhong; Jie-Kun Luo; Han-Jin Cui; Qi-Mei Zhang; Jing-Hua Zhou; Qiang Zhang
Journal:  BMC Complement Altern Med       Date:  2014-04-05       Impact factor: 3.659

Review 8.  Acupuncture and neuroregeneration in ischemic stroke.

Authors:  Qwang-Yuen Chang; Yi-Wen Lin; Ching-Liang Hsieh
Journal:  Neural Regen Res       Date:  2018-04       Impact factor: 5.135

9.  Effect of opposing needling on motor cortex excitability in healthy participants and in patients with post-stroke hemiplegia: study protocol for a single-blind, randomised controlled trial.

Authors:  Mindong Xu; Yinyu Zi; Jianlu Wu; Nenggui Xu; Liming Lu; Jiahui Liu; Yanling Yu; Haofeng Mo; Weifeng Wen; Xiaorong Tang; Wenjuan Fan; Yu Zhang; Churong Liu; Wei Yi; Lin Wang
Journal:  Trials       Date:  2021-07-22       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.